Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Stealth BioTherapeutics Q2 EPS $(0.03) Misses $(0.02) Estimate

Stealth BioTherapeutics (NASDAQ:MITO) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent decrease over losses of $(0.02) per share
byBill Haddad
August 5, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Stealth BioTherapeutics (NASDAQ:MITO) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent decrease over losses of $(0.02) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts